High dose therapy followed by autologous peripheral blood stem cell transplantation as a first line treatment for multiple myeloma: a Korean Multicenter Study.

We conducted a phase II multicenter trial to estimate the response and survival of patients with newly diagnosed multiple myeloma to high dose melphalan therapy followed by autologous peripheral blood stem cell transplantation. Eligible patients who had undergone induction with vincristine, adriamyc...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Bang, Soo-Mee, Cho, Eun Kyung, Suh, Cheolwon, Yoon, Sung-Soo, Seong, Chu Myung, Cho, Kyung Sam, Kang, Yoon Goo, Park, Seonyang, Ahn, Myung-Ju, Park, Young Suk, Oh, Doyeun, Kim, Hugh C., Jung, Chul Won, Kim, Samyong, Lee, Jae Hoon
Format: Artigo
Idioma:Inglês
Publicat: Korean Academy of Medical Sciences 2003
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3055099/
https://ncbi.nlm.nih.gov/pubmed/14555819
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars